 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 157
Date: March 22, 2024
Time for CLL Topics’s members and donors to take a bow: our efforts at sponsoring and funding the green tea EGCG clinical trial at the Mayo Clinic have been written up in the Wall Street Journal. Guys, this is serious attention from the national media for our advocacy! I hope this article will make a few more patients aware of the resources available to them online. The internet has made it possible for us to share our resources and become a community that can influence the path of research. PC and I are proud of what we have achieved by working together as a community. Please do visit the Topics website to read the article. You can also access it by clicking on this link: http://webreprints.djreprints.com/1434330670171.html
At last count, more than 300 donors have made it possible for us to sponsor this clinical trial. In the next few weeks we will be announcing our support for a couple more. Please accept this very special acknowledgement of your generosity.
Be well,
Chaya
__________
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
